Filing Details

Accession Number:
0001127602-15-005312
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-10 17:11:50
Reporting Period:
2015-02-08
Filing Date:
2015-02-10
Accepted Time:
2015-02-10 17:11:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1577061 Alfred Sandrock Biogen Idec Inc.
225 Binney Street
Cambridge MA 02142
Grp Svp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-08 1,277 $0.00 15,851 No 4 M Direct
Common Stock Disposition 2015-02-08 421 $402.00 15,430 No 4 F Direct
Common Stock Disposition 2015-02-09 856 $398.05 14,574 No 4 S Direct
Common Stock Acquisiton 2015-02-09 1,824 $0.00 16,398 No 4 M Direct
Common Stock Disposition 2015-02-09 681 $396.88 15,717 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2015-02-08 1,277 $0.00 1,277 $0.00
Common Stock Restricted Stock Unit Disposition 2015-02-09 1,824 $0.00 1,824 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,278 2016-02-08 No 4 M Direct
0 2015-02-09 No 4 M Direct
Footnotes
  1. Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).